临床肺科杂志
臨床肺科雜誌
림상폐과잡지
Journal of Clinical Pulmonary Medicine
2015年
10期
1805-1807
,共3页
谢华%张志远%张俊丽%刘美岑%宋迪%赵海涛%马壮%陈萍
謝華%張誌遠%張俊麗%劉美岑%宋迪%趙海濤%馬壯%陳萍
사화%장지원%장준려%류미잠%송적%조해도%마장%진평
创机械通气%哮喘%共存病
創機械通氣%哮喘%共存病
창궤계통기%효천%공존병
mechanical ventilation%asthma%coexisting disease
目的 分析住院哮喘患者行机械通气治疗情况. 方法 采取回顾性方法,收集6年内住院哮喘患者中行机械通气治疗的患者年龄、性别、所患疾病种类和住院费用等临床资料,分别进行统计和分类汇总. 结果 2009~2014年共有1327哮喘患者住院治疗,行机械通气的患者占6. 6%,其中行无创机械通气治疗占3. 4%,有创机械通气占3. 2%. 行机械通气治疗哮喘患者倾向于高龄、入住ICU,出现II型呼吸衰竭.有创机械通气治疗组与无创治疗组和非机械通气组比较,肺炎、糖尿病、脑血管病和肾功能不全等伴发疾病多. 无创机械通气治疗组患者,男性多,合并支气管扩张多,冠心病、肝功能不全等合并症与非机械通气组相似. 进一步进行危险因素分析,发现无创机械通气危险因素较少,只有年龄大于65岁、男性、入住ICU、出现II型呼吸衰竭和合并支气管扩张;有创机械通气的危险因素较多,为年龄大于65岁、入住ICU、出现II型呼吸衰竭、合并肺炎、冠心病、糖尿病、脑血管疾病和肝、肾功能不全. 非机械通气哮喘住院患者住院人均费用为11667元,而机械通气治疗的住院哮喘患者人均费用42460元,与非机械通气患者比较,差异有显著性统计学意义(P<0. 05). 住院非机械通气哮喘患者死亡率为0. 2%,无创通气治疗组死亡率为2. 2%,有创通气治疗组死亡率为27. 9%,各组间差异有显著统计学意义(P<0. 05). 结论 高龄和合并症是导致患者行机械通气治疗的主要原因.
目的 分析住院哮喘患者行機械通氣治療情況. 方法 採取迴顧性方法,收集6年內住院哮喘患者中行機械通氣治療的患者年齡、性彆、所患疾病種類和住院費用等臨床資料,分彆進行統計和分類彙總. 結果 2009~2014年共有1327哮喘患者住院治療,行機械通氣的患者佔6. 6%,其中行無創機械通氣治療佔3. 4%,有創機械通氣佔3. 2%. 行機械通氣治療哮喘患者傾嚮于高齡、入住ICU,齣現II型呼吸衰竭.有創機械通氣治療組與無創治療組和非機械通氣組比較,肺炎、糖尿病、腦血管病和腎功能不全等伴髮疾病多. 無創機械通氣治療組患者,男性多,閤併支氣管擴張多,冠心病、肝功能不全等閤併癥與非機械通氣組相似. 進一步進行危險因素分析,髮現無創機械通氣危險因素較少,隻有年齡大于65歲、男性、入住ICU、齣現II型呼吸衰竭和閤併支氣管擴張;有創機械通氣的危險因素較多,為年齡大于65歲、入住ICU、齣現II型呼吸衰竭、閤併肺炎、冠心病、糖尿病、腦血管疾病和肝、腎功能不全. 非機械通氣哮喘住院患者住院人均費用為11667元,而機械通氣治療的住院哮喘患者人均費用42460元,與非機械通氣患者比較,差異有顯著性統計學意義(P<0. 05). 住院非機械通氣哮喘患者死亡率為0. 2%,無創通氣治療組死亡率為2. 2%,有創通氣治療組死亡率為27. 9%,各組間差異有顯著統計學意義(P<0. 05). 結論 高齡和閤併癥是導緻患者行機械通氣治療的主要原因.
목적 분석주원효천환자행궤계통기치료정황. 방법 채취회고성방법,수집6년내주원효천환자중행궤계통기치료적환자년령、성별、소환질병충류화주원비용등림상자료,분별진행통계화분류회총. 결과 2009~2014년공유1327효천환자주원치료,행궤계통기적환자점6. 6%,기중행무창궤계통기치료점3. 4%,유창궤계통기점3. 2%. 행궤계통기치료효천환자경향우고령、입주ICU,출현II형호흡쇠갈.유창궤계통기치료조여무창치료조화비궤계통기조비교,폐염、당뇨병、뇌혈관병화신공능불전등반발질병다. 무창궤계통기치료조환자,남성다,합병지기관확장다,관심병、간공능불전등합병증여비궤계통기조상사. 진일보진행위험인소분석,발현무창궤계통기위험인소교소,지유년령대우65세、남성、입주ICU、출현II형호흡쇠갈화합병지기관확장;유창궤계통기적위험인소교다,위년령대우65세、입주ICU、출현II형호흡쇠갈、합병폐염、관심병、당뇨병、뇌혈관질병화간、신공능불전. 비궤계통기효천주원환자주원인균비용위11667원,이궤계통기치료적주원효천환자인균비용42460원,여비궤계통기환자비교,차이유현저성통계학의의(P<0. 05). 주원비궤계통기효천환자사망솔위0. 2%,무창통기치료조사망솔위2. 2%,유창통기치료조사망솔위27. 9%,각조간차이유현저통계학의의(P<0. 05). 결론 고령화합병증시도치환자행궤계통기치료적주요원인.
Objective To analyze the curative effect of mechanical ventilation in the treatment of inpatients with asthma. Methods The clinical data of inpatients with asthma received mechanical ventilation during recent 6 years were retrospectively analyzed, including age, sex, type of illness and hospitalization costs. Results there were a total of 1327 cases of asthmatic patients from 2009 to 2014, and 6. 6% of them were given mechanical ventilation, including 3. 4% of non-invasive mechanical ventilation and 3. 2% of invasive mechanical ventilation. Those patients received mechanical ventilation were tend to be senior citizens, staying in ICU and complicating with typeⅡrespira-tory failure. The incidence of pneumonia, diabetes, cerebrovascular disease and renal failure was higher in the venti-lation group than in the control group. The non-invasive mechanical ventilation group had the characteristics of more male and bronchiectasis. Further analysis of the risk factors found that the risk factors of non-invasive mechanical ventilation only included older than 65 years, male, stay in ICU, type Ⅱ respiratory failure and bronchiectasis, but the risk factors of invasive mechanical ventilation included older than 65 years, stay in ICU, typeⅡrespiratory fail-ure, pneumonia, coronary heart disease, diabetes, cerebrovascular disease, and liver and kidney dysfunction. The average hospitalization cost was 11,667 yuan for non-ventilation patients, and 42,460 yuan for ventilation patients (P<0. 05). The mortality of the non-ventilation group was 0. 2%, 2. 2% of the non-invasive ventilation group, and 27. 9% of the invasive ventilation group (P<0. 05). Conclusion The main risk factors causing asthma inpatients received mechanical ventilation are old age and complications.